PERRY MICHAEL S
SEC Form 4 insider trading activity
PERRY MICHAEL S has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, PERRY MICHAEL S is listed as Director at ARROWHEAD PHARMACEUTICALS, INC. Inside the rolling window, PERRY MICHAEL S reported no open-market purchases and 2 open-market sales totaling $2.0M in ARWR. The largest disclosed transaction in the window is a sale of 11,600 ARWR shares on Aug 18, 2026, worth $1.0M.
Companies traded
Other insiders at ARWR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has PERRY MICHAEL S made?
PERRY MICHAEL S has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does PERRY MICHAEL S trade?
PERRY MICHAEL S has filed SEC Form 4 disclosures for 1 company, including ARWR.
When was PERRY MICHAEL S's most recent SEC Form 4 filing?
PERRY MICHAEL S's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is PERRY MICHAEL S's total buy and sell value in the current window?
Inside the rolling retention window, PERRY MICHAEL S bought $0 and sold $2.0M based on SEC Form 4 filings.
What was PERRY MICHAEL S's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,600 ARWR shares on 2026-08-18, worth $1.0M, per SEC Form 4 filings.